[ET Net News Agency, 4 December 2023] REMEGEN (09995) fell 9.6% to HK$40.8, dipping
below the 50-D SMA of HK$42.037.
It hits an intra-day low of HK$40.6, hitting an 1-month low, and an intra-day high of
HK$45.5. The total shares traded was 1.16 million, with a value of HK$49.59m. The active
buy/sell ratio is 39:61, with net selling turnover of HK$10.57m. CHINA INV INFO accounts
for greatest net responsive buying turnover of HK$3.48m, with volume weighted average
price of HK$42.559. MORGAN STANLEY HK SEC accounts for greatest net responsive selling
turnover of HK$1.35m, with volume weighted average price of HK$42.921.
Basic Information
=================
---------------------------------
Nominal 40.800 % Chg -9.63%
High 45.500 Low 40.600
Shares Tr 1.16m Turnover 49.59m
10-D SMA 44.065 %H.V 53.517
20-D SMA 44.310 VWAP 42.659
50-D SMA 42.037 RSI14 42.976
---------------------------------
Status: Dipping below the 50-D SMA, hitting an 1-month low, active buy/sell ratio is
39:61, with net selling turnover of HK$10.57m
* Suspended
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 40.80 -9.63
HUTCHMED (00013) 28.50 -2.90
GENSCRIPT BIO (01548) 20.00 -6.98
INNOVENT BIO (01801) 42.60 -3.18
EVEREST MED-B (01952) 19.54 -2.54
WUXI XDC (02268) 30.85 -4.19
WUXI BIO (02269) 33.15 -23.79*
TIGERMED (03347) 36.80 -9.36
BEIGENE (06160) 110.00 -2.65
AKESO (09926) 46.85 -3.40
---------------------------------------------
(ed)